when to use 5-alpha-reductase inhibitors (Proscar, Avodart) or PSA screening to prevent prostate cancer

July 2009

See updated FDA information concerning the use of 5-alpha reductase inhibitors and increased risk of serious forms of prostate cancer

Experts are debating when to use 5-alpha-reductase inhibitors (Proscar, Avodart) or PSA screening to prevent prostate cancer.

Proscar and Avodart. These 5-alpha-reductase inhibitors can prevent prostate cancer due to their anti-androgen effects.

Statistically, you need to treat 71 men for up to 7 years to prevent one case of prostate cancer.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote